Genelux Corporation
USD2.95
+0.05 (+1.72%)
CEO
Thomas D. Zindrick
IPO Date
2023-01-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.99
Prev. Close
$2.90
Day Low
$2.86
Day High
$2.99
52W Low
$2.29
52W High
$8.54
Market Cap
$0.11B
Volume
0.15M
| -2.5 |
| 31 Dec 2023 | FY | -498.8% | -16645.3% | -145.3% | -101.4% | 0.13 | 3.69 | -12.1 |
| 31 Dec 2022 | FY | 91.3% | -47.0% | 14.6% | -94.1% | -0.74 | 0.06 | -29.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | 53.7% | -219.0% | -0.76 | 0.26 | -8.2 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | 65.6% | -106.1% | -1.15 | 0.79 | -9.8 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | 46.9% | -354.5% | -0.72 | 0.04 | -12.5 |
| -4.4 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -42.8% | -31.8% | 0.09 | 4.20 | -5.0 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -31.2% | -23.1% | 0.07 | 4.18 | -3.7 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -25.1% | -19.2% | 0.06 | 4.67 | -3.1 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -34.2% | -25.9% | 0.07 | 4.57 | -2.1 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -19.5% | -16.1% | 0.06 | 6.47 | -3.2 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -17.5% | -14.6% | 0.06 | 6.01 | -2.1 |
| 31 Mar 2024 | Q1 | -3000.0% | -98125.0% | -52.0% | -31.8% | 0.16 | 2.72 | -4.5 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -34.8% | -24.3% | 0.13 | 3.69 | -13.9 |